FRAMEWORK COLLABORATIVE RESEARCH AGREEMENT by KEYGENE N.V. and 22nd Century Group, Inc.Framework Collaborative Research Agreement • August 5th, 2021 • 22nd Century Group, Inc. • Cigarettes • New York
Contract Type FiledAugust 5th, 2021 Company Industry JurisdictionThis First Amended and Restated Framework Collaborative Research Agreement (the “Agreement”), is executed this 16th day of April (the “Execution Date”), 2021, but is effective as of the 14th day of April 2019 (“Effective Date”) by and between Keygene N.V., a company organized and existing under the laws of The Netherlands, having its registered office at Agro Business Park 90, 6708 PW Wageningen, The Netherlands, duly represented by its co-CEO’s, Dr. Arjen van Tunen and Henny Wilpshaar, (hereinafter further referred to as “KeyGene”), and 22nd Century Group, Inc., a corporation organized and existing under the laws of State of Nevada in the United States of America, having its principal offices at 500 Seneca Street, Suite 507, Buffalo, New York 14204, United States of America, duly represented by its President and Chief Executive Officer, James A. Mish (hereinafter further referred to as “XXII”), and amends and restates in its entirety the Original Agreement (defined below) with referen
FRAMEWORK COLLABORATIVE RESEARCH AGREEMENTFramework Collaborative Research Agreement • May 7th, 2019 • 22nd Century Group, Inc. • Cigarettes • New York
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionThis Framework Collaborative Research Agreement (the “Agreement”), is made this 3rd day of April 2019 (“Effective Date”) by and between